OHLCX Market Research
Delayed

VTRS

Viatris Inc. is a global healthcare company that develops, manufactures, and markets a wide range of medicines, including generic and specialty pharmaceuticals.

−0.26 (−1.29%) Nov 20, 2026 19:42 ET Delayed
Open
19.87
High
20.09
Low
19.43
Prev close
19.88
Volume
9M
Avg vol 10
11M

Today · Market closed · opens Mon 9:30 AM

Price

VTRS chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 19.62

Strong sellNeutralStrong buy
Neutral
score +0.06 · 18 signalling
5Buy
9Neutral
4Sell

No clear lean. 5 buy, 9 neutral and 4 sell across 18 signals. Stoch RSI sits in oversold territory. Trend strength is strong (ADX 33).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 0.55 · Signal 0.65 · Hist −0.10
Sell
ADX 14
Strong trend, +DI slightly ahead
ADX 32.97 · +DI 24.42 · −DI 21.79
Buy
Parabolic SAR 0.02, 0.2
Above price, 1.50 over the close
21.12
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 20.31 · Base 19.53 · A 17.43 · B 17.16
Buy

Momentum

RSI 14
Mid-range, no extreme
52.08
Neutral
Stoch 14, 3
Low, %K still below %D
%K 38.41 · %D 50.30
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 6.75 · %D 21.55
Neutral
Williams %R 14
Mid-range, falling
−61.59
Neutral
CCI 14
Negative, above −100
−42.96
Neutral
MFI 14
Above midpoint, not overbought
62.32
Neutral
ROC 12
Price up 2.10% over 12 bars
+2.10%
Buy
AO 5, 35
Above zero, falling
1.40
Neutral
TRIX 18
Above zero
0.462
Buy
KST 10/15/20/30, 3
Below its signal line
KST 124.72 · Signal 126.89
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.47
Up 21.46 · Mid 19.73 · Low 18.00
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 20.59 · Mid 19.74 · Low 18.89
Neutral

Volume

VWAP 345-bar
Close 38.1% above VWAP
14.21
Buy
Force Index 1
Negative, sellers in control
−2.4M
Sell
ATR
0.56
2.83% of close
A/D Line
61.6M
cumulative
OBV
314.2M
cumulative
Volume Profile
15.81 – 16.71
POC · bull 426.5M · bear 421.6M · 50 / 50
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

6.22%

Change in value over the past month.

3 month return

18.68%

Change in value over the last three months.

Max drawdown

19.65%

Largest fall from a peak to the low that followed.

Standard deviation

31.83%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.77

Return above the risk-free rate per unit of volatility.

Calmar ratio

2.86

Annualised return against the maximum drawdown.

About

VTRS summary

Loading summary…

Questions

VTRS, answered

What is Viatris’ commitment to sustainability?

Viatris is dedicated to sustainability, focusing on reducing its environmental impact and promoting responsible manufacturing practices.

How does Viatris engage with healthcare professionals?

Viatris engages with healthcare professionals through educational initiatives, research collaborations, and product support programs.

How can investors stay informed about Viatris?

Investors can stay informed about Viatris through its investor relations website, which provides financial reports, press releases, and updates.

Is VTRS publicly traded?

Yes, Viatris Inc. is publicly traded on the Nasdaq under the ticker symbol VTRS.

What is the role of innovation at Viatris?

Innovation is crucial for Viatris, as it seeks to develop new formulations, delivery methods, and therapies to meet evolving patient needs.

What are Viatris’ key business segments?

Viatris operates in several key business segments, including generic pharmaceuticals, brand-name products, and over-the-counter medications.

What therapeutic areas does Viatris focus on?

Viatris focuses on a variety of therapeutic areas, including infectious diseases, oncology, and cardiovascular health.

How does Viatris support global health initiatives?

Viatris participates in global health initiatives through donations, partnerships, and programs aimed at improving health outcomes in underserved communities.

How does Viatris ensure access to medicines?

Viatris is committed to improving access to medicines by offering affordable products and engaging in partnerships with healthcare providers and governments.

What is Viatris’ approach to corporate governance?

Viatris emphasizes strong corporate governance practices to ensure accountability and transparency in its operations.

News

VTRS in the news

Reveal Your VTRS Trading Now

Achieve superior trading results with OHLCX execution platform. Our platform provides expert analysis and actionable insights for VTRS, utilizing the latest technology to refine your investment approach. Boost your investment success with us now and see the impact on your trading success!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.